Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ranevetmab (NV-01), a caninized anti-nerve growth factor (anti-NGF) monoclonal antibody (mAb), is utilized in research for alleviating pain associated with degenerative joint disease (DJD) in canines.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Ranevetmab (NV-01), a caninized anti-nerve growth factor (anti-NGF) monoclonal antibody (mAb), is utilized in research for alleviating pain associated with degenerative joint disease (DJD) in canines. |
Molecular Weight | N/A |
CAS No. | 1632282-27-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ranevetmab 1632282-27-9 inhibitor inhibit